Company Filing History:
1 out of 13 
1 out of 9 
Years Active: 2015
Title: Wolfgang Bruck: Innovator in Medical Treatments
Introduction
Wolfgang Bruck is a notable inventor based in Rosdorf, Germany. He has made significant contributions to the field of medicine, particularly in the treatment of multiple sclerosis and rheumatoid arthritis. His innovative approach has led to the development of a unique antibody that targets specific chemokine receptors.
Latest Patents
Wolfgang Bruck holds a patent related to the treatment of multiple sclerosis and/or rheumatoid arthritis. The invention involves the use of an antibody that specifically binds to the chemokine receptor CCR2. This antibody is utilized for producing a medicament aimed at treating these conditions in subjects, preferably primates or humans. Additionally, the invention includes methods for depleting monocytes in affected individuals. The patent also discusses the potential use of an antibody that binds to CD14 in conjunction with the CCR2-targeting antibody.
Career Highlights
Throughout his career, Wolfgang Bruck has worked with esteemed institutions such as the Georg-August-University Göttingen and the University of Regensburg. His research has focused on advancing medical treatments and improving patient outcomes through innovative therapies.
Collaborations
Wolfgang Bruck has collaborated with notable colleagues, including Marco Prinz and Alexander Mildner. These partnerships have contributed to the advancement of his research and the development of effective medical solutions.
Conclusion
Wolfgang Bruck's contributions to medical science, particularly through his patent for treating multiple sclerosis and rheumatoid arthritis, highlight his role as an innovator in the field. His work continues to influence the development of new therapeutic approaches.